nach oben

Supportive Care in Cancer

Erschienen in:

01.01.2010 | Original Article

Efficacy and safety of deep, continuous palliative sedation at home: a retrospective, single-institution study

verfasst von: Giampiero Porzio, Federica Aielli, Lucilla Verna, Giovanna Micolucci, Paolo Aloisi, Corrado Ficorella

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Goals

The goal of this study is to evaluate the feasibility and efficacy of palliative sedation at home (PSH) to approach refractory symptoms in dying cancer patients.

Materials and methods

Charts of 121 patients, observed by “L'Aquila per la Vita” Home Care Unit, from August 2006 to May 2008, were reviewed. Sixteen patients out of 44 who died at home (36.4%) were sedated. Indication for sedation was agitated delirium in 13 patients and dyspnea in three patients. A multistep midazolam-based protocol was administered.

Results

In all patients, a deep, prolonged, continuous sedation was obtained. No treatment-related complications were registered.

Conclusion

A midazolam-based protocol for PSH is feasible and effective. Our results need to be confirmed by prospective, multicentric, controlled studies.

Amesbury BDW, Dunphy KP (1989) The use of subcutaneous midazolam in the home care setting. Palliat Med 3(4):299–301. doi:10.1177/026921638900300411 CrossRef

Bauer T, Ritz R, Haberthur C et al (1995) Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet 346(8968):145–147. doi:10.1016/S0140-6736(95)91209-6 CrossRefPubMed

Bruera E, Sala R, Rico MA et al (2005) Effects of parenteral hydration in terminally ill cancer patients: a preliminary study. J Clin Oncol 23(10):2366–2371. doi:10.1200/JCO.2005.04.069 CrossRefPubMed

Bulli F, Miccinesi G, Biancalani E et al (2007) Continuous deep sedation in home palliative care units: case studies in the Florence area in 2000 and in 2003–2004. Minerva Anestesiol 73(5):291–298PubMed

Burke AL, Diamond PL, Hulbert J et al (1991) Terminal restlessness—its management and the role of midazolam. Med J Aust 155(7):485–487PubMed

Caraceni A, Grassi L (2003) Management. Delirium: acute confusional states in palliative medicine. Oxford University Press, New York, pp 146–150

Chamorro C, de Latorre FJ, Montero A et al (1996) Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicenter trial. Crit Care Med 24(6):932–939. doi:10.1097/00003246-199606000-00010 CrossRefPubMed

Cheng C, Roemer-Becuwe C, Pereira J (2002) When midazolam fails. J Pain Symptom Manage 23(3):256–265. doi:10.1016/S0885-3924(01)00412-2 CrossRefPubMed

Cherny NI, Portenoy RK (1994) Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care 10(2):31–38PubMed

10.

Cowan JD, Walsh D (2001) Terminal sedation in palliative medicine—definition and review of the literature. Support Care Cancer 9:403–407. doi:10.1007/s005200100235 CrossRefPubMed

11.

De Graeff A, Dean M (2007) Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards. J Palliat Med 10(1):67–86. doi:10.1089/jpm.2006.0139 CrossRefPubMed

12.

Del Fabbro E, Reddy SG, Walker P, Bruera E (2007) Pallitive sedation: when the family and consulting service see no alternative. J Palliat Med 10(2):488–492. doi:10.1089/jpm.2006.9974 CrossRefPubMed

13.

Elsayem A, Curry E III, Boohene J et al (2009) Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center. Support Care Cancer 17:53–59. doi:10.1007/s00520-008-0459-4 CrossRefPubMed

14.

Fainsinger R, Bruera E (1992) Treatment of delirium in a terminally ill patient. J Pain Symptom Manage 7(1):54–56. doi:10.1016/0885-3924(92)90108-T CrossRefPubMed

15.

Fainsinger RL, De Moissac D, Mancini I, Oneschuk D (2000) Sedation for delirium and other symptoms in terminally ill patients in Edmonton. J Palliat Care 16(2):5–10PubMed

16.

Fainsinger RL, Waller A, Bercovici M et al (2000) A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med 14(4):257–265. doi:10.1191/026921600666097479 CrossRefPubMed

17.

Grassi L, Caraceni A, Beltrami E et al (2001) Assessing delirium in cancer patients: the Italian versions of the Delirium Rating Scale and the Memorial Delirium Assessment Scale. J Pain Symptom Manage 21(1):59–68. doi:10.1016/S0885-3924(00)00241-4 CrossRefPubMed

18.

Iruela LM, Oliveros S, Marcos MA, Gilaberte I (1989) Remission of benzodiazepine-resistant delirium tremens after treatment with Laborit's lytic cocktail. Med Clin (Barc) 93(18):717

19.

Kohara H, Ueoke H, Takeyama H et al (2005) Sedation for terminally ill patients with cancer with uncontrollable physical distress. J Palliat Med 8:20–25. doi:10.1089/jpm.2005.8.20 CrossRefPubMed

20.

Lawlor PG (2002) Delirium and dehydration: some fluid for thought? Support Care Cancer 10:445–454. doi:10.1007/s00520-001-0334-z CrossRefPubMed

21.

Levy MH, Cohen SD (2005) Sedation for the relief of refractory symptoms in the imminently dying: a fine intentional line. Semin Oncol 32(2):237–246. doi:10.1053/j.seminoncol.2005.02.003 CrossRefPubMed

22.

McIver B, Walsh D, Nelson K (1994) The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Manage 9(5):341–345. doi:10.1016/0885-3924(94)90193-7 CrossRefPubMed

23.

Miccinesi G, Rietjens J, Deliens L et al (2006) Continuous deep sedation: physicians' experiences in six European countries. J Pain Symptom Manage 31(2):122–129. doi:10.1016/j.jpainsymman.2005.07.004 CrossRefPubMed

24.

Morita T, Bito S, Kurihara Y, Uchitomi Y (2005) Development of a clinical guideline for palliative sedation therapy using the Delphi method. J Palliat Med 8(4):716–729. doi:10.1089/jpm.2005.8.716 CrossRefPubMed

25.

Morita T, Hyodo I, Yoshimi T et al (2005) Association between hydratation volume and symptoms in terminally ill cancer patients with abdominal malignancies. Ann Oncol 16:640–647. doi:10.1093/annonc/mdi121 CrossRefPubMed

26.

Muller-Busch HC, Andres I, Jehser T (2003) Sedation in palliative care—a critical analysis of 7 years experience. BMC Palliat Care 2:2. doi:10.1186/1472-684X-2-2 CrossRefPubMed

27.

Peruselli C, Di Giulio P, Toscani F et al (1999) Home palliative care for terminal cancer patients: a survey on the final week of life. Palliat Med 13(3):233–241. doi:10.1191/026921699669863369 CrossRefPubMed

28.

Porzio G, Ricevuto E, Aielli F et al (2005) The Supportive Care Task Force at the University of L'Aquila: 2-years experience. Support Care Cancer 13:351–355. doi:10.1007/s00520-004-0772-5 CrossRefPubMed

29.

Ramani S, Karnad AB (1996) Long-term subcutaneous infusion of midazolam for refractory delirium in terminal breast cancer. South Med J 89(11):1101–1103. doi:10.1097/00007611-199611000-00017 CrossRefPubMed

30.

Ramsay MAE, Savage TM, Simpson BRJ, Goodwin R (1974) Controlled sedation with alpaxalone–alphadolone. BMJ 2:656–659CrossRefPubMed

31.

Sales JP (2001) Sedation and terminal care. Eur J Palliat Care 8:97–100

Titel: Efficacy and safety of deep, continuous palliative sedation at home: a retrospective, single-institution study
verfasst von: Giampiero Porzio
Federica Aielli
Lucilla Verna
Giovanna Micolucci
Paolo Aloisi
Corrado Ficorella
Publikationsdatum: 01.01.2010
Verlag: Springer-Verlag
Erschienen in: Supportive Care in Cancer / Ausgabe 1/2010
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-009-0632-4

Springer Medizin

Efficacy and safety of deep, continuous palliative sedation at home: a retrospective, single-institution study